Oversold

WAT

Same as last week
Valuation7/ 100
Cash flow & growth48/ 100
Upside potential26/ 100
Risk potential29/ 100

WAT's valuation is expensive, fundamentals are below averages, while forward estimates point to improving growth and profitability.

Valuation

Historical cheapness: current PE is 101.8× versus the full-history median of 29.5× shown in the valuation table, producing 7/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 7.2/100. The model applies a 15.7% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 31.5× (18-month half-life). The favorable scenario uses 87.8× PE and $5 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +52.5%, earnings -63.8%, operating margin -19.7 percentage points. Free cash flow is 8.6% of revenue. The business score is 47.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

The earnings calculation and the displayed scenario are different.

The earnings case uses $4.98 of EPS and a 87.8× PE, suggesting about $437.23 before the minimum is applied. Valuation history and outlook inform the PE.

The model applies a 15% minimum upside scenario, so the card shows +15%, or about $469.59. That adjusted price does not come from the EPS × PE calculation above.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $3.48 of EPS and a 83.3× PE, suggesting a share price of about $289.53 — 29% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

WAT vs Historical averages

MetricCurrentAverageRelative
PE102x31x225% higher
PE percentile995099% higher
EPS$4.01$10.5162% lower
FCF$398.5M$533.3M25% lower
Loading historical comparisons…

WAT’s earnings and cash flow are below their historical averages, while its earnings multiple is higher.

WAT Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueStrong growth
Forward profitabilityStrongly expanding
Analyst coverageBroad
Estimate dispersionTight

WAT’s outlook is generally improving, with growth expectations supporting the valuation case.

WAT PE Valuation

Loading pe valuation table…

This table applies WAT's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

WAT Earnings Per Share

Loading earnings per share…

This chart tracks WAT's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

WAT Quarterly Revenue

Loading quarterly revenue…

This chart tracks WAT's quarterly revenue over time and shows how sales are changing from year to year.

WAT Free Cash Flow

Loading free cash flow…

This chart tracks WAT's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

WAT Total Shares

Loading shares over time…

This chart tracks changes in WAT's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

WAT Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

WAT PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares WAT's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

WAT Weekly Price

Loading weekly price…

This chart uses WAT's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

WAT Weekly Moving Averages

Loading weekly moving averages…

This chart compares WAT's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

WAT Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.